Form 8-K BIOGEN INC. For: Apr 06

Go back to Form 8-K BIOGEN INC. For: Apr 06

Biogen expects $34 million charge in first quarter 2026

April 6, 2026 6:36 AM EDT

Biogen Inc. (NASDAQ: BIIB) announced it expects to record approximately $34 million in acquired in-process research and development, upfront and milestone expenses on a pre-tax basis during the first quarter of 2026.

The charge is projected to impact both GAAP and non-GAAP net income per... More